Photo by impulsq from unsplash
Myeloid growth factors (MGFs) are given as supportive care to patients receiving myelosuppressive chemotherapy to reduce the incidence of neutropenia. This selection from the NCCN Guidelines for MGFs focuses on… Click to show full abstract
Myeloid growth factors (MGFs) are given as supportive care to patients receiving myelosuppressive chemotherapy to reduce the incidence of neutropenia. This selection from the NCCN Guidelines for MGFs focuses on the evaluation of regimen- and patient-specific risk factors for the development of febrile neutropenia (FN), the prophylactic use of MGFs for the prevention of chemotherapy-induced FN, and assessing the risks and benefits of MGF use in clinical practice.
Keywords:
myeloid growth;
oncology;
growth factors;
clinical practice
Journal Title: Journal of the National Comprehensive Cancer Network : JNCCN
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of the National Comprehensive Cancer Network : JNCCN
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!